Biocon Limited (NSE:BIOCON)
330.05
-0.55 (-0.17%)
Jun 6, 2025, 3:30 PM IST
Biocon Revenue
In the fiscal year ending March 31, 2025, Biocon had annual revenue of 152.62B INR with 3.43% growth. Biocon had revenue of 44.17B in the quarter ending March 31, 2025, with 12.76% growth.
Revenue
152.62B
Revenue Growth
+3.43%
P/S Ratio
2.59
Revenue / Employee
9.35M
Employees
16,315
Market Cap
395.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Biocon News
- 4 days ago - Top stocks to watch today, June 3: HCLTech, Mphasis, Britannia Industries, Torrent Power, Biocon and more - Business Upturn
- 4 days ago - Stocks to watch on June 3: Biocon, PTC India Financial, HCL Tech, Yes Bank, Maruti, Reliance Infra, Aptus Value, Zinka Logistics, Adani Group in focus - Business Upturn
- 4 days ago - Biocon receives CDSCO approval for its Liraglutide drug in India - Business Upturn
- 10 days ago - ‘Metro Mentor’ moment: Kiran Mazumdar-Shaw ditches car, hops on Bengaluru Metro with Exxon Mobil’s ‘Iron Lady’; calls ride ‘quick way to avoid traffic’ - The Times of India
- 13 days ago - Biocon Biologics receives UK MHRA approval for YESINTEK, Biosimilar Ustekinumab - Business Upturn
- 17 days ago - Biocon subsidiary and Yoshindo expand access to Ustekinumab Biosimilar in Japan - Business Upturn
- 22 days ago - Stocks to watch on May 16: Websol, Godrej Industries, Crompton, Biocon, RVNL, Lupin, BLS in focus after Q4 earnings and updates - Business Upturn
- 25 days ago - JP Morgan, Goldman Sachs & more: Top stocks on brokers' radar for today - The Times of India